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1a. The terms “White, Black/ African, Asian/Indian, and Coloured” refer
to demographic markers that were chosen for their historical
significance. These markers are important as accurate user profiles
assist in identifying vulnerable population subgroups and in planning
effective intervention programmes. 
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Introduction
Findings from national epidemiological research point to high
rates of untreated alcohol and other drug (AOD) use disorders
in South Africa.1,2 The high prevalence of untreated AOD
problems is also apparent from the large burden these
problems place on South African health care and legal
systems.3,4 Compared to the other provinces in the country, the
Western Cape has significantly higher rates of AOD
problems.1 Cape Town, the capital of the Western Cape is
particularly afflicted, with the highest proportion of alcohol
and drug positive arrestees3 and emergency room patients
compared to other major cities in the country.4 Taken together,
these findings highlight the need for accessible AOD
treatment services in Cape Town.
Despite the demand for and documented benefits of AOD
treatment, access to treatment is limited in South Africa.5 While
the limited availability of AOD services restricts access to
treatment for all South Africans, treatment seems relatively
more difficult to access for people from Black/African and
Coloured1a communities disadvantaged during the course of
apartheid.6 Treatment is also relatively more difficult for
women to access than men, with women comprising roughly a
quarter of the treatment population.7 Women from
disadvantaged communities are particularly
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underrepresented in AOD treatment, accounting for only a
small proportion of the total population of women in treatment.
While there is limited data on AOD treatment need among
women from disadvantaged communities, the high prevalence
of foetal alcohol syndrome in disadvantaged communities in
the Western Cape8 and high levels of AOD abuse among
Black/African and Coloured women in Cape Town9 suggest
that women from these communities have many unmet
treatment needs. 
In order to improve AOD treatment utilization among
women from disadvantaged communities, it is important to
identify the unique profile of factors associated with AOD
treatment initiation so that any gendered barriers to treatment
utilization can be addressed. Studies conducted in the USA
have identified several barriers to AOD treatment utilization
that are specific to women (including childcare needs, the fear
of losing child custody, a lack of information about how to get
into treatment, concurrent mental health difficulties, economic
barriers, being a victim of physical or sexual abuse, and
stigma).10-12 However, the extent to which these findings are
applicable to the South African context is unknown. This is
largely because AOD treatment services research in South
Africa has not compared recipients of services with
community-based samples of untreated persons. This has
made it difficult to identify factors that facilitate or restrict AOD
treatment utilization for men and women from disadvantaged
communities and has hampered the development of
interventions to improve utilization. This study hopes to
redress this gap by exploring differences in the pattern of
predictors for AOD treatment utilization among men and
women. More specifically, the study aimed to identify gender
differences on the profile of variables associated with
treatment utilization (and non-utilization) for persons from
disadvantaged communities in Cape Town, South Africa. 
The theoretical basis for this study was the Behavioral
Model of Health Services Utilization (BHSU).13 The BHSU is
widely used to examine health services use, including AOD
services.12-14 The BHSU suggests that health service use is
partly a function of the separate and combined influence of
predisposing factors, factors that enable or restrict health
service use, and need variables. Predisposing characteristics,
such as demographic and attitudinal-belief variables, exist
within the individual prior to the onset of a particular health
need and predispose a person to use services. Enabling
factors represent the actual ability of an individual to obtain
health services and include affordability factors (due to
income and health insurance), geographic accessibility and
awareness of services, as well as psychological and cognitive
factors (such as psychological functioning). Finally, need
variables reflect internal and external perceptions that illness
levels are severe enough to require health services.13,15
Method
Study design
This study used a case-control design to compare cases and
controls on a range of variables thought to be associated with
the outcome of interest, namely AOD treatment utilization. This
study defined cases as persons from disadvantaged
communities with AOD problems who reported AOD treatment
utilization in the 12 months preceding the study. Controls were
defined as persons from disadvantaged communities who had
not used AOD treatment prior to this study, despite having
AOD problems that required treatment. To control for selection
bias, frequency matching techniques were used to match
cases and controls on gender and race dimensions. To limit
recall bias, we used time-line follow back (TLFB) procedures
to collect retrospective data.16
Recruitment and data collection procedures
From June 2006 through January 2007, convenience samples of
men and women were recruited from AOD treatment
programmes and communities using snowball sampling
techniques. Cases (“treatment use”) were identified at
nonprofit AOD treatment facilities in the Cape Town metropole,
which served as starting points for sampling. Counsellors from
these facilities were trained to screen recipients of services for
study eligibility. Of the 440 persons screened, all met the
inclusion criteria. Having established eligibility, the
counsellors obtained written informed consent from potential
cases so that locator information could be gathered and
passed on to the study’s fieldworkers. Fieldworkers then
contacted these recruits to obtain written informed consent to
conduct an interview. Only six recruits refused to participate in
the interview. This interview took approximately 90 minutes to
complete during which time an Access to treatment interview
questionnaire (ATQ) was administered in a face-to-face format. 
Controls (“non-use”) were recruited by a team of
experienced fieldworkers. To ensure controls represented the
population of persons with AOD problems in disadvantaged
communities, subjects were recruited from a range of these
communities. Two residential areas from each of the six sub-
structures of the Cape Town metropole were selected as key
focus areas for sampling. To be selected, the area had to
consistently appear in the South African Community
Epidemiology Network on Drug Use’s list of top ten residential
areas for AOD problems. Selected areas also had to be
classified as a “Black” or “Coloured” residential area under
the apartheid regime, have high levels of health and social
problems, and be a low-income area. Fieldworkers entered
these communities by contacting organisations, leaders, and
individuals with known interests in the AOD field and asking
them to identify potential recruits. Informants were assured
that their anonymity would be protected. Informants were
easily able to identify controls. This is partly due to the social
structure of poorer South African communities where people
live together in close confines and often depend on each other
for survival. In such communities, keeping involvement in drug
use private is difficult. 
Fieldworkers then contacted potential controls (who served
as starting points for snowball sampling) to obtain consent to
screen them for study eligibility. These individuals did not
seem offended about being asked to participate in the study
and responses were mostly positive. The interviewer-
administered screener took approximately five minutes to
complete and collected information on area of residence,
gender, age, race, and income in the last 30 days. Controls
were also screened for current AOD problems to objectively
assess their need for treatment. The Texas Christian University
(TCU) Drug Screen was used for this purpose.17 For this
screen, a composite score of 3 or greater indicates relatively
severe drug-related problems that correspond to a DSM-IV-TR
drug dependence diagnosis.18 All controls scored above this
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cut-off point, indicating an objective need for treatment. Of the
559 potential recruits screened, only four did not meet the
study’s eligibility criteria. An overall response rate of 98.3%
was obtained. For eligible participants, fieldworkers obtained
written consent to conduct a full interview. This interview took
approximately 90 minutes to complete during which time the
ATQ was administered. Fieldworkers provided participants
with refreshments, feedback, and referrals to AOD services
where requested. 
Ethical approval for this study was granted by the Ethics
Review Board of the Faculty of Humanities at the University of
Cape Town.
Participants
To be selected for inclusion in the study, potential recruits had
to be at least 18 years old, self-identify as Black/African or
Coloured, earn less than ZAR2500 per month2a, have AOD
problems (either treated or untreated), and provide informed
consent to participate in the study. The final sample consisted
of 434 cases and 555 controls (N = 989). Of these controls,
approximately 46 were selected from each recruitment area.
Chi-square tests of association revealed that cases and
controls did not differ by gender or race. Similarly,
independent sample t tests showed that the mean age and
level of education did not differ among cases and controls
(Table I). 
Measures
The Access to Treatment interview schedule (ATQ) was
compiled to examine AOD treatment utilization among South
African populations. The ATQ includes items that explore
treatment use, treatment need, factors thought to predispose
individuals to using treatment, and factors thought to enable or
restrict treatment use. 
Use of AOD treatment
The criterion variable for this study was AOD treatment
utilization. This was assessed by the question: “Have you ever
received treatment for AOD problems? “ This item had a “yes”
(1) or a “no” (0) response.
Need for treatment 
The questions: “Do you think you have an AOD problem?” and
“Have other people suggested that you need help to change
your use of AODs?” examined internally and externally
perceived treatment need, respectively. These items had a
“yes” (1) or “no” (0) response. The Stages of Change,
Readiness and Treatment Eagerness Scale (SOCRATES-8D)
measured readiness to change AOD use; a situational indicator
of perceived need.19 The SOCRATES consists of the problem
recognition, ambivalence and the taking steps to change
subscales for which this study obtained alpha coefficients
ranging between .91 and .95. 
Predisposing factors 
Predisposing factors included the demographic variables of
age and gender and the social-structural variables of
race/ethnicity, education level, and neighbourhood
disadvantage. Education level was based on the number of
years of education received, treated as a continuous variable.
The Neighbourhood Environment Scale (NES) measured
neighbourhood disadvantage.20 For this study, the wording of
the NES was adapted for an adult population. A Cronbach
alpha coefficient of .82 was obtained for this scale. 
Enabling and restricting factors
A 5-item “Affordability scale” was constructed to measure the
extent to which treatment and transport costs hampered
utilization. These items were taken from Miller and Tonigan’s
(1995) “Barriers questionnaire”.21 Items are rated on a 5-point
Likert scale and aggregated responses averaged to give a
composite score, with higher scores indicating more cost
barriers. A Cronbach alpha coefficient of .84 was obtained for
this scale. Participants were also asked whether competing
financial priorities (such as the need to pay for food) limited
treatment use. Responses for this item were coded as “yes” (1)
or “no” (0). 
Awareness of AOD treatment services was examined
through asking participants to list all known treatment
services. The number of known AOD treatment facilities was
then calculated, with larger numbers indicating greater
awareness of services. In addition, the geographic
accessibility of treatment was examined through asking
participants to estimate the time it took (in 15 minute intervals)
to travel to the nearest service. 
Psychological functioning was examined through the use of
TCU’s depression and anxiety scales. For these scales, higher
scores indicate greater levels of depression and anxiety.22 This
study obtained Cronbach alpha coefficients ranging from .81
to .92 for these scales. The 10-item Stigma Consciousness
Scale was used to examine internalized stigma related to
participants’ AOD use.23 This study obtained a Cronbach alpha
coefficient of .84 for the scale. 
Table I: Demographic information for the overall sample (N = 989)
Variable Cases Control Chi-square/ t -test (p) Overall 
Male 54.4% (236) 50.3% (279) 1.65 (0.20) 52.1% (515)
Female 45.6% (198) 49.7% (276) 47.9% (474)
Black/African 50.9% (221) 50.3% (279) 0.04 (0.84) 50.6% (500)
Coloured 49.1% (213) 49.7% (276) 49.4% (489)
Mean age in years(SD) 24.95 (4.81) 25.43 (5.98) 1.38 (0.17) 25.22 (5.51)
Mean education - grade (SD) 11.55 (1.57) 11.45 (1.52) -0.95 (0.34) 11.50 (1.54)
Total (N) 434 555 - 989
2a. At the time of the study USD 1= ZAR 9
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Abstinence-specific social support was examined via the
TCU social support scale which measures the extent to which
others act as external supports for treatment and abstinence.22
Higher composite scores indicate greater levels of support.
This study obtained a Cronbach alpha coefficient of .77 for the
scale. 
A 10-item “Treatment concerns” scale was constructed to
measure concerns about the AOD treatment process. Items
were taken from Miller and Tonigan’s (1995) “Barriers
questionnaire”.21 For this scale, items are aggregated to give a
composite score and higher scores reflect more treatment
concerns. A Cronbach alpha coefficient of .90 was obtained for
this scale. 
Analysis procedures
Bivariate comparisons of the utilization variable and the
predisposing, enabling and need measures were conducted
separately for each gender group. Chi-square tests of
association were conducted on categorical variables by
utilization and odds ratios were calculated to measure the
strength of these associations. Independent sample t-tests
were used to compare the utilization groups on continuous
variables. The final step was to conduct logistic regression
analyses to determine which predisposing, enabling and need
factors independently predicted treatment utilization.
Utilization was regressed separately for male and female
participants so that the unique profile of variables associated
with utilization for each gender could be identified. For each
regression analysis, all predisposing, enabling and need
variables significantly associated with utilization in bivariate





For males, the NES was the only predisposing factor
significantly associated with treatment use. Men who did not
access treatment obtained higher scores on this scale
compared with men who accessed treatment. This measure
was not significantly associated with utilization for women.
None of the other predisposing variables examined in this
study were significantly associated with utilization (Table II).
Need variables
The categorical variable “others suggesting the need for AOD
treatment” was significantly associated with utilization for both
genders (χ2 (1, N = 515) = 21.34, p <0.001 for males; χ2 (1, N
= 474) = 36.75, p <0.001 for females). The odds of utilizing
treatment increased almost three-fold for male participants
(OR = 2.92; CI (95): 1.83-4.66) and almost six-fold for female
participants (OR = 5.81; CI (95): 3.13-10.79) who had
someone suggest that they needed help for their AOD
problem. Significant differences also were found between
cases and controls on the SOCRATES subscales. For both
genders, the treatment use group reported higher scores on
all three subscales than the treatment non-use group (Table II).
Enabling/restricting variables
The variable “competing financial priorities” was significantly
associated with utilization for both genders (χ2 (1, N = 515)
=41.99, p < 0.001 for males and χ2 (1, N = 474) = 36.75, p <
0.001 for females). Men with no competing financial priorities
had three-fold greater odds of accessing treatment than men
with competing financial demands (OR = 3.23; CI (95): 2.27-
Table II: Independent sample t tests for continuous predisposing, need and enabling variables by utilization for each gender group
Variables Males Females
No use Controls Treatment use t value (df) No use Controls Treatment use t value (df)
(N = 279) (N = 236) (N = 276) Cases (N = 198)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Predisposing variables
Age 25.80 (5.78) 25.25 (4.93) 1.14 (513) 25.05 (6.17) 24.60 (4.65) .87 (472)
Education (years) 11.49 (1.54) 11.58 (1.54) -.69 (498) 11.42 (1.51) 11.51 (1.60) -.61 (409)
NES 42.16 (3.23) 40.53 (5.14) 4.36 (513)*** 42.57 (3.60) 42.48 (4.77) 0.21 (472)
Need for treatment variables
Socrates- Problem recognition 30.94 (8.22) 36.77 (5.95) -6.42 (513)*** 29.00 (8.10) 37.02 (6.57) -10.04 (472)***
Socrates-Ambivalence 33.37 (7.93) 37.83 (7.57) -5.48 (513)*** 30.92 (9.38) 37.57 (7.79) -8.50 (472)***
Socrates- Taking steps 33.7 (5.40) 34.30 (6.39) -8.54(513)*** 31.09 (5.68) 32.08 (4.90) -18.96 (472)***
Enabling variables
Treatment concerns 25.88 (8.52) 28.52 (8.03) -3.61 (507)*** 26.99 (8.55) 31.11 (7.08) -5.55 (472)***
Stigma consciousness 7.73 (1.48) 8.21 (1.78) -3.30 (513)*** 7.52 (1.57) 9.04 (1.31) -11.16 (472)***
Abstinence support 35.69 (5.64) 38.05 (4.27) -5.26 (513)*** 34.86 (5.46) 36.70 (5.01) -3.81 (445)***
Depression 33.12 (6.65) 38.79 (7.44) -9.04 (476)*** 31.90 (7.96) 37.91 (8.40) -7.68 (414)***
Anxiety 34.64 (8.17) 40.26 (7.30) -8.17 (513)*** 33.59 (9.11) 37.91 (8.40) -5.27 (472)***
Number of known treatment centres 2.03 (0.82) 3.81 (0.80) -25.08 (502)*** 2.06 (1.03) 3.99 (0.86) -21.48 (472)***
Time to treatment 3.57 (0.61) 2.72 (0.75) 14.16 (513)*** 3.76 (0.46) 2.73 (0.75) 18.52 (472)***
Affordability barriers 38.72 (27.60) 6.46 (9.91) 15.29 (513)*** 38.80 (6.01) 28.27 (8.89) 15.38 (472)***
*p < .05; ** p < .01; *** p < .001
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4.76). Similarly, women without competing financial priorities
had almost six times greater odds of accessing treatment
compared to women with competing demands (OR = 5.56;
CI (95): 3.71-8.33). 
For both genders, cases obtained higher scores on the
treatment concerns and stigma consciousness scales than
controls. Cases also obtained significantly higher scores on
the TCU abstinence support, depression, and anxiety scales
than controls. For men and women, cases reported
significantly shorter travelling times to the nearest treatment
centre, fewer affordability barriers and greater awareness of
treatment services than controls (Table II). 
Logistic regression of utilization
Utilization was regressed separately for each gender while
controlling for the potential confounding effect of race. A test
of the full model versus the model with the intercept only was
statistically significant for men (χ2 (9; N = 519) = 527.48, p <
.001) and women (χ2 (10; N = 474) = 556.23, α < .001). These
models accounted for approximately 86% (Nagelkerke R2 =
.857) and 93% (Nagelkerke R2 = .929) of the estimated
variance in utilization for men and women, respectively.
According to the Hosmer and Lemeshow test, the models
were a good fit for the data (χ2 (8; N = 515) = 5.09, p = .747
for men; χ2 (8; N = 474) = .27, p = .998 for women). 
For men and women, few treatment need and
predisposing variables were significantly associated with
utilization after statistically adjusting for the other variables in
the model. For men, NES was the only predisposing measure
significantly (albeit weakly) associated with utilization. For
every one unit increase in the scale (reflecting greater
disadvantage), the odds of men not utilizing treatment
increased by a multiplicative factor of 1.25. No predisposing
variables were significantly associated with treatment
utilization for women (Table III). For the need variables, the
probability of utilization increased for men with greater levels
of problem recognition and for women who were taking
positive steps to change their AOD use. However, these
aspects of readiness to change were weakly associated with
utilization (Table III). 
Several enabling variables were significantly and strongly
associated with utilization for men and women. Awareness of
services was positively associated with utilization. For every
additional treatment centre that a man or woman knew of, the
odds of utilizing treatment increased by a multiplicative factor
of 5.85 and 7.09, respectively. Geographic accessibility was
negatively associated with utilization. For every 15 minute
increase in travelling time to treatment, the odds of not
accessing treatment increased by a multiplicative factor of
9.09 for men and 11.10 for women. Affordability barriers and
competing financial priorities also were significant partial
predictors of utilization for both genders. Men and women
without competing financial priorities had almost a 3 and 17
times greater likelihood of accessing treatment compared to
their respective counterparts with competing financial
priorities. In addition, every one-unit increase in the
affordability barriers scale augmented the odds of not
accessing treatment 1.30 times for women and 1.14 times for
men. Barriers related to treatment concerns were associated
with utilization for men and women, with every one unit
increase in this scale increasing the odds of utilizing treatment
by a multiplicative factor of 1.10 and 1.27, respectively. Finally,
stigma consciousness was positively associated with utilization
for women only. Every one-unit increase in this scale increased
the odds of accessing treatment by a multiplicative factor of
3.14 (Table III).
Table III: Summary of multiple logistic regression analyses using predisposing, enabling and need factors as predictors of
substance abuse treatment utilization # a
Predictor Variables Male (N =515) Female (N =474)
b SE Wald (df) OR (95% CI) b SE Wald (df) OR (95% CI)
Predisposing variables
NES -.23 .06 16.80 (1)*** .80 (.71-.89) - - - -
Need for treatment variables
Socrates problem recognition .10 .04 6.09 (1)* 1.11 (1.02-1.20) - - - -
Socrates taking steps -.01 .03 .05 (1) .99 (.93-1.06) .23 .05 17.57 (1)*** 1.26 (1.13-1.40)
Enabling/restricting variables
Awareness: 
Number of known treatment centres 1.77 .23 58.84 (1)*** 5.85 (3.72-9.18) 1.93 .36 20.62 (1)*** 7.09 (4.52-12.26)
Geographic access: 
Travelling time to treatment -2.23 .33 45.31(1)*** .11 (.06-.21) -2.40 .59 14.99 (1)*** .09 (.03-.32)
Affordability: 
No competing financial priorities 1.07 .43 45.31 (1)*** 2.91 (1.25-6.76) 2.86 .69 16.74 (1)*** 17.39 (4.43-68.32)
Affordability barriers -.13 .03 24.59 (1)*** .88 (.84-.93) -.25 .06 18.54 (1)*** .78 (.69-.87)
Treatment concerns .06 .02 6.52 (1)* 1.06 (1.01-1.11) .24 .06 16.46 (1)*** 1.27 (1.13-1.42)
Stigma consciousness - - - - 1.14 .26 19.58 (1)*** 3.14 (1.89-5.20)
# adjusted for race
a Blank spaces indicate that the variable did not enter the equation; * = p < .05, ** = p < .01, *** = p < .001.
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Discussion
Our findings suggest that although men and women from
disadvantaged communities in Cape Town share a core set of
predictors for AOD treatment utilization, women from these
communities appear more vulnerable to the effects of these
barrier variables than their male counterparts. 
More specifically, awareness of AOD treatment services is
an important enabling resource for men and women from
disadvantaged communities, with greater awareness
increasing the likelihood of treatment utilization. However as
the association between awareness and treatment utilization
was stronger for women than for men, it seems that this
predictor variable holds greater importance for women’s use
of treatment services than for men. The nature of women’s
social networks might help account for this finding. The role
that significant others play in facilitating treatment use for
women is well documented, with social networks supportive
of treatment buffering against the effects of limited
awareness.24 Partial support for this explanation is provided
by the finding from bivariate analyses that women for whom
significant others had suggested the need for treatment had
double the odds of accessing treatment compared to their
male counterparts. The significance of this variable suggests
that interventions targeted at the level of the social network
may be an effective strategy for improving awareness of and
access to treatment, particularly for women. This possibility
requires further investigation in a study that directly examines
the impact of social networks on awareness of and use of
treatment services. 
In addition, our findings highlight the role that financial
barriers play in limiting AOD treatment utilization for men and
women from disadvantaged communities. Greater
affordability concerns (related to treatment and transport
costs) and the presence of competing financial priorities
diminish the chances of AOD treatment utilization, even after
controlling for the influence of predisposing and treatment
need variables. While financial barriers limit treatment use for
men and women, these barriers are stronger determinants of
utilization for women from disadvantaged communities
relative to their male counterparts. This suggests that women
from these communities are more vulnerable to the effects of
financial barriers than men. The saliency of financial concerns
as a treatment barrier for women is not altogether surprising
as women in South Africa have relatively lower incomes than
men.25 In addition, like many other African countries, South
Africa is still largely a patriarchal society in which men often
control women’s incomes.26 As a result, many women in South
Africa may not have access to an independent income to pay
for treatment. 
The increased susceptibility of women to financial barriers
may also account for the finding that geographic access
barriers (such as lengthy travel times to treatment)
disproportionately affect AOD treatment utilization for women
from disadvantaged communities compared to men. Findings
from previous studies suggest that financial barriers often
compound geographic access barriers.27 For South African
women with competing financial priorities and limited
income, lengthy travel times may be unaffordable due to the
costs associated with public transport as well as the potential
loss of income associated with difficult and lengthy commutes.
Regardless of the reasons for these gender differences, these
findings are worrisome as they suggest that women from
disadvantaged communities experience greater difficulty in
accessing treatment than men. Service providers thus need to
consider ways of reducing geographic access and financial
barriers for people from disadvantaged communities in
general and women from these communities in particular.
One strategy for reducing these barriers would be to
introduce mobile outpatient AOD services into these
communities. Not only would such services improve treatment
availability, but they would also reduce women’s travel time to
and the costs of AOD treatment. Another strategy for reducing
financial and geographic access barriers would be to provide
prospective female clients from disadvantaged communities
with tokens for public transport or transport services. 
Apart from these shared set of predictors, this study found
a few variations in the profile of variables associated with
AOD treatment utilization among men and women from
disadvantaged communities. First, the SOCRATES problem
recognition subscale, was significantly (albeit weakly)
associated with access for men, but not for women. In
contrast, the SOCRATES taking steps to change subscale was
weakly associated with treatment utilization for women but not
for men. These differences can be understood by examining
the SOCRATES more closely. The SOCRATES scale measures
three dimensions of readiness to change that correspond to
different stages of change as conceptualised by the
Transtheoretical Model of Behavioural Change.19 Compared
to the “Taking steps” subscale which refers to an action stage,
the problem recognition subscale relates to an earlier stage
of change, the contemplation phase. Our findings therefore
suggest that men are more likely to access treatment earlier
on in their decision to change their drug use behaviours than
women. Therefore, these differences probably reflect the
greater difficulties that women experience in accessing
treatment relative to their male counterparts. 
In addition, perceived stigma played a positive role in
women’s use of AOD treatment, but was not associated with
men’s use of treatment services. This is surprising as it
contradicts findings from earlier research in which the
disproportionate degree to which stigma is experienced by
female AOD users relative to men is thought to hinder rather
than promote their entry into treatment.11 One possible
explanation lies in this study’s measurement of perceived
stigma. This study employed the stigma consciousness scale
which measures perceptions of being judged negatively on
the basis of one’s AOD use rather than on the basis of one’s
use of AOD treatment services.23 It is quite possible that high
levels of stigma around problematic AOD use cause women
such distress that it propels them to seek treatment in order to
alleviate this distress. Earlier qualitative research which
reported that women experience stigma in relation to their
problematic use of AODs rather than their use of AOD
services28 provides some support for this explanation. An
alternative explanation is that this effect could have been
influenced by a sampling bias as potential female controls
that experienced stigma may have been less likely to
participate in the study than controls who had not
experienced stigma. However, given this study’s low refusal
rate, it is unlikely that a sampling bias is responsible for this
unexpected finding. 
Findings from this study should be considered in the light
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of several limitations. First, the use of a case-control design
precludes a temporal examination of the factors associated
with treatment utilization and thus inferences about causality
cannot be drawn. Related to this, while we were able to
compare factors associated with utilization for men and
women, our matched design rules out an examination of
gender differences in the likelihood of AOD treatment use.
Third, our rather crude conceptualisation of access prevented
us from exploring whether there were differences between
participants who had unsuccessfully attempted to access
treatment and those who had never tried to access treatment.
Fourth, our strict selection criteria may have truncated the
variability of the sample and contributed to most
predisposing variables not being associated with treatment
utilization. In addition, as this study sample was limited to
adults from disadvantaged communities in Cape Town, the
extent to which findings from this study are representative of
more rural or other urban regions in South Africa is
questionable. As the Western Cape Province is well resourced
in terms of health and social services, relative to the other
provinces in South Africa25, it is possible that structural and
population-level barriers are even more salient in other
provinces. Finally, our study did not examine two categories of
variables that are strongly predictive of women’s rather than
men’s non use of treatment services in other contexts: 1)
concerns relating to dependent children (including access to
child care whilst attending treatment and concerns around
child custody) and 2) histories of victimisation.10-12
These limitations highlight the need for further research
on AOD treatment utilization among men and women in South
Africa. Future research should include longitudinal
prospective studies that track men and women with AOD
problems over time and allow researchers to unpack the
factors that precipitate AOD treatment utilization for each
gender. These longitudinal studies will also allow researchers
to differentiate between individuals who needed services and
did not try to access them, those that attempted to access
treatment and were unsuccessful, and those that successfully
accessed treatment. Future studies should attempt to include
a broader range of variables thought specifically to impact on
women’s use of treatment services. To address concerns
about the external validity of findings, studies on factors
associated with AOD treatment utilization in other parts of the
country (particularly rural regions) and for other population
subgroups (such as adolescents) are required. In addition,
researchers should conduct experimental intervention studies
that test whether reducing geographic access and
affordability barriers and improving service awareness
impact positively on AOD treatment utilization for men and
women from disadvantaged communities. 
Conclusion
Despite some limitations this study provides good evidence
that women from disadvantaged communities in Cape Town
do not have equal opportunities to access AOD treatment
relative to their male counterparts; with women being more
vulnerable to the effects of awareness, affordability and
geographic access barriers than men. Taken together, these
findings suggest the need for targeted interventions that
address gendered barriers to treatment utilization. Various
strategies can be used to improve women’s use of AOD
treatment. For service planners, new services should be
placed in locations easily accessible by public transport and
in communities with high service needs and poor service
coverage. Second, outpatient mobile clinics offer a low cost
and geographically accessible means of providing AOD
services, particularly as these clinics have limited
infrastructural costs and can be moved between and within
communities. Third, as financial concerns often compound
geographic access barriers service providers should
consider providing prospective female clients from poor
communities with transport services. Service providers can
also reduce the competing demands on female clients’
limited financial resources through linking female clients with
poverty alleviation programs that offer tangible support (in
the form of food, shelter or economic assistance). Finally,
service providers should consider using community-based
outreach workers to improve awareness of AOD treatment
among women residing in disadvantaged communities.
Through educating women about when, where and how to
access services, outreach workers can positively impact on
women’s use of AOD treatment services. 
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